The global generic drug market is projected to grow from USD 519.11 billion in 2025 to USD 926.54 billion by 2034, at a compound annual growth rate (CAGR) of 6.55%. This growth is driven by increasing demand for cost-effective medicines amid rising chronic diseases worldwide and the comparable efficacy of generic drugs to branded ones. North America leads the market due to its large elderly population and healthcare infrastructure, while Asia-Pacific and Europe also show strong demand. Challenges include limited awareness and availability in rural areas, but ongoing research and development offer growth opportunities.
TCL SunPower showcased its latest solar energy solutions at SNEC in Shanghai and Intersolar Europe in Munich, featuring next-generation Back-Contact solar modules. These innovations target residential, commercial, and industrial markets with high-eff...
TCL SunPower announced new solar energy products featuring next-generation back contact technology at SNEC in Shanghai and Intersolar Europe in Munich. Their innovations include high-efficiency residential and commercial solar panels with long warran...
TCL SunPower announced its participation in the SNEC and Intersolar Europe trade shows, where it will reveal its new generation of integrated energy systems for residential, commercial, and industrial markets. These systems feature advanced back-cont...
Ademi LLP is investigating Verra Mobility for potential securities fraud related to inaccurate statements about its financials and business operations. The probe centers on Verra Mobility's failure to timely disclose contract negotiations with Avis B...
Nuwellis, a medical technology company focused on cardiorenal conditions, has closed a public offering raising approximately $6 million. The offering included common stock, pre-funded warrants, and Series C and D warrants, with proceeds aimed at supp...
